These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26561779)

  • 21. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ultrastructural features of virus infected hepatocytes in patients with pathology of the hepatobiliary organs].
    Medvetskiĭ EB; Tumasova EP; Khil'chenko EA
    Klin Khir (1962); 1990; (11):16-7. PubMed ID: 2074670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Dysbiosis for the Treatment of Liver Disease.
    Anand G; Zarrinpar A; Loomba R
    Semin Liver Dis; 2016 Feb; 36(1):37-47. PubMed ID: 26870931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiota: the liver debugs the system.
    Bordon Y
    Nat Rev Immunol; 2014 Jul; 14(7):430-1. PubMed ID: 24903913
    [No Abstract]   [Full Text] [Related]  

  • 25. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
    Jiang L; Schnabl B
    Physiology (Bethesda); 2020 Jul; 35(4):261-274. PubMed ID: 32490750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gut microbiota and the liver: implications for clinical practice.
    Quigley EM; Monsour HP
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):723-32. PubMed ID: 24134195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanism of gut-microbiota-liver axis in the pathogenesis of intestinal failure-associated liver disease].
    Fan SX; Wang J; Li Q; Li YS; Guan WX; Li JS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jan; 24(1):94-100. PubMed ID: 33461259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiota, immunity and the liver.
    Vaikunthanathan T; Safinia N; Lombardi G; Lechler RI
    Immunol Lett; 2016 Mar; 171():36-49. PubMed ID: 26835593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The intestinal microbiota in chronic liver disease.
    Henao-Mejia J; Elinav E; Thaiss CA; Flavell RA
    Adv Immunol; 2013; 117():73-97. PubMed ID: 23611286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The humoral immunity indices of patients with diseases of the hepatobiliary system].
    Kushnir VE; Sidorova LL; Kuklia IuI; Fedorich VN
    Vrach Delo; 1990 Sep; (9):60-1. PubMed ID: 2284773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunopathology of human biliary cell epithelium.
    Chuang YH; Lan RY; Gershwin ME
    Semin Immunopathol; 2009 Sep; 31(3):323-31. PubMed ID: 19533127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases.
    Liu J; Yang D; Wang X; Asare PT; Zhang Q; Na L; Shao L
    Front Cell Infect Microbiol; 2022; 12():774335. PubMed ID: 35444959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systems biology perspective for studying the gut microbiota in human physiology and liver diseases.
    Altay O; Nielsen J; Uhlen M; Boren J; Mardinoglu A
    EBioMedicine; 2019 Nov; 49():364-373. PubMed ID: 31636011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiome, liver immunology, and liver diseases.
    Wang R; Tang R; Li B; Ma X; Schnabl B; Tilg H
    Cell Mol Immunol; 2021 Jan; 18(1):4-17. PubMed ID: 33318628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Microbiome and the Liver: The Basics.
    Victor DW; Quigley EM
    Semin Liver Dis; 2016 Sep; 36(4):299-305. PubMed ID: 27997968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulin A and liver diseases.
    Inamine T; Schnabl B
    J Gastroenterol; 2018 Jun; 53(6):691-700. PubMed ID: 29075899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of microbiota to the intestinal physicochemical barrier.
    Malago JJ
    Benef Microbes; 2015; 6(3):295-311. PubMed ID: 25273548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut-liver axis: gut microbiota in shaping hepatic innate immunity.
    Wu X; Tian Z
    Sci China Life Sci; 2017 Nov; 60(11):1191-1196. PubMed ID: 28840534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Microbiota in Intestinal and Liver Disease.
    Jones RM; Neish AS
    Annu Rev Pathol; 2021 Jan; 16():251-275. PubMed ID: 33234022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Problems in the etiology and pathogenesis of inflammatory diseases of the liver and biliary tracts in children today].
    Dorofeĭchuk VG; Mikheeva SM; Volkova AA; Kliueva ZhI; Bogdanovich NE
    Vopr Okhr Materin Det; 1974 Oct; 19(10):54-6. PubMed ID: 4446450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.